Intraduodenal milk protein concentrate augments the glycemic and food intake suppressive effects of DPP-IV inhibition

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 306, Issue 3, 2014, Pages

  Olivos, Diana R ^a   McGrath, Lauren E ^a   Turner, Christopher A ^a   Montaubin, Orianne ^a   Mietlicki Baase, Elizabeth G ^a   Hayes, Matthew R ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Dairy; Diabetes; GLP 1; Insulin; Obesity

Indexed keywords

DIPEPTIDYL PEPTIDASE IV; GLUCAGON LIKE PEPTIDE 1; MILK PROTEIN; SITAGLIPTIN; SODIUM CHLORIDE; SOYBEAN PROTEIN;

ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR THERAPY; CONTROLLED STUDY; DIET THERAPY; DIETARY INTAKE; FOOD INTAKE; GASTROINTESTINAL TRACT; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HYPOTHESIS; MACRONUTRIENT; MALE; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN SECRETION; RAT;

DAIRY; DIABETES; GLP-1; INSULIN; OBESITY;

ANIMALS; BLOOD GLUCOSE; DIPEPTIDYL PEPTIDASE 4; EATING; GLUCAGON-LIKE PEPTIDE 1; HYPOGLYCEMIC AGENTS; MALE; MILK PROTEINS; OBESITY; PYRAZINES; RATS; RATS, SPRAGUE-DAWLEY; TRIAZOLES;

EID: 84893418537     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00358.2013     Document Type: Article

References (61)

1. Azadbakht L, Mirmiran P, Esmaillzadeh A, Azizi F. Dairy consumption is inversely associated with the prevalence of the metabolic syndrome in Tehranian adults. Am J Clin Nutr 82: 523-530, 2005.
2. Baum JI, O'Connor JC, Seyler JE, Anthony TG, Freund GG, Layman DK. Leucine reduces the duration of insulin-induced PI 3-kinase activity in rat skeletal muscle. Am J Physiol Endocrinol Metab 288: E86-E91, 2005.
3. Brenner LA, Ritter RC. Type A CCK receptors mediate satiety effects of intestinal nutrients. Pharmacol Biochem Behav 54: 625-631, 1996.
4. Calbet JA, Holst JJ. Gastric emptying, gastric secretion and enterogastrone response after administration of milk proteins or their peptide hydrolysates in humans. Eur J Nutr 43: 127-139, 2004.
5. Chang J, Wu T, Greenfield JR, Samocha-Bonet D, Horowitz M, Rayner CK. Effects of intraduodenal glutamine on incretin hormone and insulin release, the glycemic response to an intraduodenal glucose infusion, and antropyloroduodenal motility in health and type 2 diabetes. Diabetes Care 36: 2262-2265, 2013.
6. Chen L, Magliano DJ, Zimmet PZ. The worldwide epidemiology of type 2 diabetes mellitus-present and future perspectives. Nat Rev Endocrinol 8: 228-236, 2012.
7. Chen Q, Reimer RA. Dairy protein and leucine alter GLP-1 release and mRNA of genes involved in intestinal lipid metabolism in vitro. Nutrition 25: 340-349, 2009.
8. Covasa M, Ritter RC. Attenuated satiation response to intestinal nutrients in rats that do not express CCK-A receptors. Peptides 22: 1339-1348, 2001.
9. Diepvens K, Haberer D, Westerterp-Plantenga M. Different proteins and biopeptides differently affect satiety and anorexigenic/orexigenic hormones in healthy humans. Int J Obes (Lond) 32: 510-518, 2008.
10. Drucker DJ, Sherman SI, Bergenstal RM, Buse JB. The safety of incretin-based therapies-review of the scientific evidence. J Clin Endocrinol Metab 96: 2027-2031, 2011.
11. Eller LK, Reimer RA. Dairy protein attenuates weight gain in obese rats better than whey or casein alone. Obesity (Silver Spring) 18: 704-711, 2010.
12. Flegal KM, Carroll MD, Ogden CL, Curtin LR. Prevalence and trends in obesity among US adults, 1999-2008. JAMA 303: 235-241, 2010.
13. Fraser KA, Raizada E, Davison JS. Oral-pharyngeal-esophageal and gastric cues contribute to meal-induced c-fos expression. Am J Physiol Regul Integr Comp Physiol 268: R223-R230, 1995.
14. Frid AH, Nilsson M, Holst JJ, Bjorck IM. Effect of whey on blood glucose and insulin responses to composite breakfast and lunch meals in type 2 diabetic subjects. Am J Clin Nutr 82: 69-75, 2005.
15. Geraedts MC, Troost FJ, Fischer MA, Edens L, Saris WH. Direct induction of CCK and GLP-1 release from murine endocrine cells by intact dietary proteins. Mol Nutr Food Res 55: 476-484, 2011.
16. Giralt M, Vergara P. Glucagonlike peptide-1 (GLP-1) participation in ileal brake induced by intraluminal peptones in rat. Dig Dis Sci 44: 322-329, 1999.
17. Gunnarsson PT, Winzell MS, Deacon CF, Larsen MO, Jelic K, Carr RD, Ahren B. Glucose-induced incretin hormone release and inactivation are differently modulated by oral fat and protein in mice. Endocrinology 147: 3173-3180, 2006.
18. Hall WL, Millward DJ, Long SJ, Morgan LM. Casein and whey exert different effects on plasma amino acid profiles, gastrointestinal hormone secretion and appetite. Br J Nutr 89: 239-248, 2003.
19. Hayes MR. Neuronal and intracellular signaling pathways mediating GLP-1 energy balance and glycemic effects. Physiol Behav 106: 413-416, 2012.
20. Hayes MR, Bradley L, Grill HJ. Endogenous hindbrain glucagon-like peptide-1 receptor activation contributes to the control of food intake by mediating gastric satiation signaling. Endocrinology 150: 2654-2659, 2009.
21. Hayes MR, Chory FM, Gallagher CA, Covasa M. Serotonin type-3 receptors mediate cholecystokinin-induced satiation through gastric distension. Am J Physiol Regul Integr Comp Physiol 291: R115-R123, 2006.
22. Hayes MR, Covasa M. Gastric distension enhances CCK-induced Foslike immunoreactivity in the dorsal hindbrain by activating 5-HT3 receptors. Brain Res 1088: 120-130, 2006.
23. Hayes MR, De Jonghe BC, Kanoski SE. Role of the glucagon-likepeptide-1 receptor in the control of energy balance. Physiol Behav 100: 503-510, 2010.
24. Hayes MR, Kanoski SE, De Jonghe BC, Leichner TM, Alhadeff AL, Fortin SM, Arnold M, Langhans W, Grill HJ. The common hepatic branch of the vagus is not required to mediate the glycemic and food intake suppressive effects of glucagon-like-peptide-1. Am J Physiol Regul Integr Comp Physiol 301: R1479-R1489, 2011.
25. Holst JJ. The physiology of glucagon-like peptide 1. Physiol Rev 87: 1409-1439, 2007.
26. Kanoski SE, Zhao S, Guarnieri DJ, Dileone RJ, Yan J, De Jonghe BC, Bence KK, Hayes MR, Grill HJ. Endogenous leptin receptor signaling in the medial nucleus tractus solitarius affects meal size and potentiates intestinal satiation signals. Am J Physiol Endocrinol Metab 303: E496-E503, 2012.
27. Kokrashvili Z, Mosinger B, Margolskee RF. Taste signaling elements expressed in gut enteroendocrine cells regulate nutrient-responsive secretion of gut hormones. Am J Clin Nutr 90: 822S-825S, 2009.
28. Liddle RA, Green GM, Conrad CK, Williams JA. Proteins but not amino acids, carbohydrates, or fats stimulate cholecystokinin secretion in the rat. Am J Physiol Gastrointest Liver Physiol 251: G243-G248, 1986.
29. Lovshin JA, Drucker DJ. Incretin-based therapies for type 2 diabetes mellitus. Nat Rev Endocrinol 5: 262-269, 2009.
30. Ma J, Stevens JE, Cukier K, Maddox AF, Wishart JM, Jones KL, Clifton PM, Horowitz M, Rayner CK. Effects of a protein preload on gastric emptying, glycemia, and gut hormones after a carbohydrate meal in diet-controlled type 2 diabetes. Diabetes Care 32: 1600-1602, 2009.
31. Madsbad S, Krarup T, Deacon CF, Holst JJ. Glucagon-like peptide receptor agonists and dipeptidyl peptidase-4 inhibitors in the treatment of diabetes: a review of clinical trials. Curr Opin Clin Nutr Metab Care 11: 491-499, 2008.
32. Mazda T, Yamamoto H, Fujimura M, Fujimiya M. Gastric distensioninduced release of 5-HT stimulates c-fos expression in specific brain nuclei via 5-HT3 receptors in conscious rats. Am J Physiol Gastrointest Liver Physiol 287: G228-G235, 2004.
33. Mrestani-Klaus C, Fengler A, Faust J, Brandt W, Wrenger S, Reinhold D, Ansorge S, Neubert K. N-terminal HIV-1 Tat nonapeptides as inhibitors of dipeptidyl peptidase IV. Conformational characterization. Adv Exp Med Biol 477: 125-129, 2000.
34. Pfeuffer M, Schrezenmeir J. Milk and the metabolic syndrome. Obes Rev 8: 109-118, 2007.
35. Poddar KH, Hosig KW, Nickols-Richardson SM, Anderson ES, Herbert WG, Duncan SE. Low-fat dairy intake and body weight and composition changes in college students. J Am Diet Assoc 109: 1433-1438, 2009.
36. Raybould HE. Gut chemosensing: interactions between gut endocrine cells and visceral afferents. Auton Neurosci 153: 41-46, 2010.
37. Reidelberger RD, Heimann D, Kelsey L, Hulce M. Effects of peripheral CCK receptor blockade on feeding responses to duodenal nutrient infusions in rats. Am J Physiol Regul Integr Comp Physiol 284: R389-R398, 2003.
38. Reimer MK, Holst JJ, Ahren B. Long-term inhibition of dipeptidyl peptidase IV improves glucose tolerance and preserves islet function in mice. Eur J Endocrinol 146: 717-727, 2002.
39. Reimer RA, Darimont C, Gremlich S, Nicolas-Metral V, Ruegg UT, Mace K. A human cellular model for studying the regulation of glucagonlike peptide-1 secretion. Endocrinology 142: 4522-4528, 2001.
40. Rocca AS, LaGreca J, Kalitsky J, Brubaker PL. Monounsaturated fatty acid diets improve glycemic tolerance through increased secretion of glucagon-like peptide-1. Endocrinology 142: 1148-1155, 2001.
41. Ruttimann EB, Arnold M, Geary N, Langhans W. GLP-1 antagonism with exendin (9-39) fails to increase spontaneous meal size in rats. Physiol Behav 100: 291-296, 2010.
42. Ryan AT, Feinle-Bisset C, Kallas A, Wishart JM, Clifton PM, Horowitz M, Luscombe-Marsh ND. Intraduodenal protein modulates antropyloroduodenal motility, hormone release, glycemia, appetite, and energy intake in lean men. Am J Clin Nutr 96: 474-482, 2012.
43. Ryan AT, Luscombe-Marsh ND, Saies AA, Little TJ, Standfield S, Horowitz M, Feinle-Bisset C. Effects of intraduodenal lipid and protein on gut motility and hormone release, glycemia, appetite, and energy intake in lean men. Am J Clin Nutr 300: 200-211, 2013.
44. Sadry SA, Drucker DJ. Emerging combinatorial hormone therapies for the treatment of obesity and T2DM. Nat Rev Endocrinol 2013.
45. Salehi A, Gunnerud U, Muhammed SJ, Ostman E, Holst JJ, Bjorck I, Rorsman P. The insulinogenic effect of whey protein is partially mediated by a direct effect of amino acids and GIP on beta-cells. Nutr Metab 9: 48, 2012.
46. Sherwin R, Jastreboff AM. Year in diabetes 2012: The diabetes tsunami. J Clin Endocrinol Metab 97: 4293-4301, 2012.
47. Tahara A, Matsuyama-Yokono A, Nakano R, Someya Y, Shibasaki M. Hypoglycaemic effects of antidiabetic drugs in streptozotocin-nicotinamide-induced mildly diabetic and streptozotocin-induced severely diabetic rats. Basic Clin Pharmacol Toxicol 103: 560-568, 2008.
48. Tarantola E, Bertone V, Milanesi G, Capelli E, Ferrigno A, Neri D, Vairetti M, Barni S, Freitas I. Dipeptidylpeptidase-IV, a key enzyme for the degradation of incretins and neuropeptides: activity and expression in the liver of lean and obese rats. Eur J Histochem 56: e41, 2012.
49. Teegarden D. The influence of dairy product consumption on body composition. J Nutr 135: 2749-2752, 2005.
50. Vetter ML, Faulconbridge LF, Webb VL, Wadden TA. Behavioral and pharmacologic therapies for obesity. Nat Rev Endocrinol 6: 578-588, 2010.
51. Wadden TA, Berkowitz RI, Womble LG, Sarwer DB, Phelan S, Cato RK, Hesson LA, Osei SY, Kaplan R, Stunkard AJ. Randomized trial of lifestyle modification and pharmacotherapy for obesity. N Engl J Med 353: 2111-2120, 2005.
52. Wadden TA, Butryn ML, Wilson C. Lifestyle modification for the management of obesity. Gastroenterology 132: 2226-2238, 2007.
53. Wadden TA, Fujioka K, Toubro S, Gantz I, Erondu NE, Chen M, Suryawanshi S, Carofano W, Johnson-Levonas AO, Shapiro DR, Kaufman KD, Heymsfield SB, Amatruda JM. A randomized trial of lifestyle modification and taranabant for maintaining weight loss achieved with a low-calorie diet. Obesity (Silver Spring) 18: 2301-2310, 2010.
54. Waget A, Cabou C, Masseboeuf M, Cattan P, Armanet M, Karaca M, Castel J, Garret C, Payros G, Maida A, Sulpice T, Holst JJ, Drucker DJ, Magnan C, Burcelin R. Physiological and pharmacological mechanisms through which the DPP-4 inhibitor sitagliptin regulates glycemia in mice. Endocrinology 152: 3018-3029, 2011.
55. Williams DL, Baskin DG, Schwartz MW. Evidence that intestinal glucagon-like-1 peptide plays a physiological role in satiety. Endocrinology 150: 1680-1687, 2008.
56. Willing AE, Berthoud HR. Gastric distension-induced c-fos expression in catecholaminergic neurons of rat dorsal vagal complex. Am J Physiol Regul Integr Comp Physiol 272: R59-R67, 1997.
57. Woerle HJ, Carneiro L, Derani A, Goke B, Schirra J. The role of endogenous incretin secretion as amplifier of glucose-stimulated insulin secretion in healthy subjects and patients with type 2 diabetes. Diabetes 61: 2349-2358, 2012.
58. Yox DP, Brenner L, Ritter RC. CCK-receptor antagonists attenuate suppression of sham feeding by intestinal nutrients. Am J Physiol Regul Integr Comp Physiol 262: R554-R561, 1992.
59. Zemel MB. Proposed role of calcium and dairy food components in weight management and metabolic health. Phys Sportsmed 37: 29-39, 2009.
60. Zemel MB. The role of dairy foods in weight management. J Am Coll Nutr 24: 537S-546S, 2005.
61. Zhou J, Keenan MJ, Losso JN, Raggio AM, Shen L, McCutcheon KL, Tulley RT, Blackman MR, Martin RJ. Dietary whey protein decreases food intake and body fat in rats. Obesity (Silver Spring) 19: 1568-1573, 2011.